These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31575655)

  • 1. Targeting Histone Chaperone FACT Complex Overcomes 5-Fluorouracil Resistance in Colon Cancer.
    Song H; Zeng J; Roychoudhury S; Biswas P; Mohapatra B; Ray S; Dowlatshahi K; Wang J; Band V; Talmon G; Bhakat KK
    Mol Cancer Ther; 2020 Jan; 19(1):258-269. PubMed ID: 31575655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone chaperone FACT complex inhibitor CBL0137 interferes with DNA damage repair and enhances sensitivity of medulloblastoma to chemotherapy and radiation.
    Song H; Xi S; Chen Y; Pramanik S; Zeng J; Roychoudhury S; Harris H; Akbar A; Elhag SS; Coulter DW; Ray S; Bhakat KK
    Cancer Lett; 2021 Nov; 520():201-212. PubMed ID: 34271103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the FACT Complex Targets Aberrant Hedgehog Signaling and Overcomes Resistance to Smoothened Antagonists.
    Mo J; Liu F; Sun X; Huang H; Tan K; Zhao X; Li R; Jiang W; Sui Y; Chen X; Shen K; Zhang L; Ma J; Zhao K; Tang Y
    Cancer Res; 2021 Jun; 81(11):3105-3120. PubMed ID: 33853831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma.
    Carter DR; Murray J; Cheung BB; Gamble L; Koach J; Tsang J; Sutton S; Kalla H; Syed S; Gifford AJ; Issaeva N; Biktasova A; Atmadibrata B; Sun Y; Sokolowski N; Ling D; Kim PY; Webber H; Clark A; Ruhle M; Liu B; Oberthuer A; Fischer M; Byrne J; Saletta F; Thwe le M; Purmal A; Haderski G; Burkhart C; Speleman F; De Preter K; Beckers A; Ziegler DS; Liu T; Gurova KV; Gudkov AV; Norris MD; Haber M; Marshall GM
    Sci Transl Med; 2015 Nov; 7(312):312ra176. PubMed ID: 26537256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression.
    Shen J; Chen M; Lee D; Law CT; Wei L; Tsang FH; Chin DW; Cheng CL; Lee JM; Ng IO; Wong CC; Wong CM
    Gut; 2020 Feb; 69(2):329-342. PubMed ID: 31439637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
    Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ
    Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
    Ahn JY; Lee JS; Min HY; Lee HY
    Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137.
    Wang J; Sui Y; Li Q; Zhao Y; Dong X; Yang J; Liang Z; Han Y; Tang Y; Ma J
    Cell Death Dis; 2020 Dec; 11(12):1029. PubMed ID: 33268769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,3-Bis(2-chloroethyl)-1-nitrosourea enhances the inhibitory effect of resveratrol on 5-fluorouracil sensitive/resistant colon cancer cells.
    Das D; Preet R; Mohapatra P; Satapathy SR; Kundu CN
    World J Gastroenterol; 2013 Nov; 19(42):7374-88. PubMed ID: 24259968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curaxins: anticancer compounds that simultaneously suppress NF-κB and activate p53 by targeting FACT.
    Gasparian AV; Burkhart CA; Purmal AA; Brodsky L; Pal M; Saranadasa M; Bosykh DA; Commane M; Guryanova OA; Pal S; Safina A; Sviridov S; Koman IE; Veith J; Komar AA; Gudkov AV; Gurova KV
    Sci Transl Med; 2011 Aug; 3(95):95ra74. PubMed ID: 21832239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs.
    Nesher E; Safina A; Aljahdali I; Portwood S; Wang ES; Koman I; Wang J; Gurova KV
    Cancer Res; 2018 Mar; 78(6):1431-1443. PubMed ID: 29339544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer.
    Lee JH; Lee SW
    Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
    Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
    Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
    Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression.
    Wang W; Guo W; Li L; Fu Z; Liu W; Gao J; Shu Y; Xu Q; Sun Y; Gu Y
    Biochem Pharmacol; 2016 Dec; 121():8-17. PubMed ID: 27693317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone chaperone complex FACT promotes proliferative switch of G
    Bi L; Xie C; Yao M; Thae Hnit SS; Vignarajan S; Wang Y; Wang Q; Xi Z; Xu H; Li Z; de Souza P; Tee A; Wong M; Liu T; Zhao X; Zhou J; Xu L; Dong Q
    Int J Cancer; 2019 Jul; 145(1):164-178. PubMed ID: 30548853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-552 deficiency mediates 5-fluorouracil resistance by targeting SMAD2 signaling in DNA-mismatch-repair-deficient colorectal cancer.
    Zhao P; Ma YG; Zhao Y; Liu D; Dai ZJ; Yan CY; Guan HT
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):427-439. PubMed ID: 31087138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT101 exerts a synergetic efficacy in gastric cancer patients with 5-FU based treatment through promoting apoptosis and autophagy.
    Wei X; Duan W; Li Y; Zhang S; Xin X; Sun L; Gao M; Li Q; Wang D
    Oncotarget; 2016 Jun; 7(23):34430-41. PubMed ID: 27144437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.
    Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Enoki T; Li TS; Hamano K
    J Cell Mol Med; 2015 Jul; 19(7):1569-81. PubMed ID: 25689483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.